Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2

EMBO Rep. 2011 Dec 23;13(1):44-51. doi: 10.1038/embor.2011.221.

Abstract

The meiosis-specific synaptonemal complex protein SYCP3 has been reported to be aberrantly expressed in tumours. However, in contrast to its well-defined function in meiosis, its possible role in mitotic cells is entirely unknown. Here, we show that SYCP3 is expressed in a range of primary tumours and that it impairs chromosomal integrity in mitotic cells. Expression of SYCP3 inhibits the homologous recombination (HR) pathway mediated by RAD51, inducing hypersensitivity to DNA-damaging agents such as a poly(ADP-ribose) polymerase (PARP) inhibitor and chromosomal instability. SYCP3 forms a complex with BRCA2 and inhibits its role in HR. These findings highlight a new mechanism for chromosomal instability in cancer and extend the range of PARP-inhibitor sensitive tumours to those expressing SYCP3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aneuploidy
  • BRCA2 Protein / metabolism*
  • Cell Cycle Proteins
  • Chromosomal Instability
  • DNA Damage / radiation effects
  • DNA Repair / genetics
  • DNA Repair / radiation effects
  • DNA-Binding Proteins
  • Drug Resistance, Neoplasm / genetics
  • Gene Silencing
  • Hep G2 Cells
  • Homologous Recombination*
  • Humans
  • Mitosis / genetics*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Protein Binding
  • Rad51 Recombinase / metabolism
  • Radiation Tolerance / genetics
  • Sister Chromatid Exchange

Substances

  • BRCA2 Protein
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Nuclear Proteins
  • Poly(ADP-ribose) Polymerase Inhibitors
  • SYCP3 protein, human
  • Rad51 Recombinase